Jane Street’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-63,922
| Closed | -$4.35M | – | 10891 |
|
|
2022
Q3 | $4.35M | Sell |
63,922
-165,937
| -72% | -$9.15M | ﹤0.01% | 2824 |
|
|
2022
Q2 | $7.34M | Buy |
229,859
+18,467
| +9% | +$541K | ﹤0.01% | 2125 |
|
|
2022
Q1 | $7.32M | Buy |
211,392
+97,073
| +85% | +$2.9M | ﹤0.01% | 2429 |
|
|
2021
Q4 | $3.35M | Buy |
114,319
+53,592
| +88% | +$1.66M | ﹤0.01% | 3514 |
|
|
2021
Q3 | $1.55M | Buy |
60,727
+16,713
| +38% | +$491K | ﹤0.01% | 5010 |
|
|
2021
Q2 | $1.54M | Buy |
44,014
+11,161
| +34% | +$436K | ﹤0.01% | 4871 |
|
|
2021
Q1 | $1.34M | Sell |
32,853
-63,578
| -66% | -$2.92M | ﹤0.01% | 4857 |
|
|
2020
Q4 | $4.18M | Buy |
96,431
+64,235
| +200% | +$3.17M | ﹤0.01% | 2351 |
|
|
2020
Q3 | $1.78M | Sell |
32,196
-71,646
| -69% | -$4.55M | ﹤0.01% | 3225 |
|
|
2020
Q2 | $6.56M | Buy |
+103,842
| New | +$7.12M | ﹤0.01% | 1548 |
|
|
2020
Q1 | – | Sell |
-7,005
| Closed | -$469K | – | 6218 |
|
|
2019
Q4 | $557K | Sell |
7,005
-7,157
| -51% | -$424K | ﹤0.01% | 3567 |
|
|
2019
Q3 | $687K | Sell |
14,162
-12,480
| -47% | -$650K | ﹤0.01% | 3107 |
|
|
2019
Q2 | $1.4M | Buy |
26,642
+14,673
| +123% | +$843K | ﹤0.01% | 2262 |
|
|
2019
Q1 | $634K | Buy |
11,969
+4,711
| +65% | +$232K | ﹤0.01% | 3384 |
|
|
2018
Q4 | $298K | Buy |
7,258
+302
| +4% | +$11.3K | ﹤0.01% | 4074 |
|
|
2018
Q3 | $264K | Sell |
6,956
-19,820
| -74% | -$878K | ﹤0.01% | 4372 |
|
|
2018
Q2 | $1.21M | Buy |
26,776
+9,154
| +52% | +$417K | ﹤0.01% | 2515 |
|
|
2018
Q1 | $851K | Buy |
17,622
+7,132
| +68% | +$398K | ﹤0.01% | 2875 |
|
|
2017
Q4 | $413K | Buy |
10,490
+4,043
| +63% | +$151K | ﹤0.01% | 3398 |
|
|
2017
Q3 | $200K | Buy |
+6,447
| New | +$181K | ﹤0.01% | 4140 |
|
|
2017
Q2 | – | Sell |
-8,780
| Closed | -$324K | – | 5035 |
|
|
2017
Q1 | $324K | Buy |
+8,780
| New | +$221K | ﹤0.01% | 3337 |
|
|
2016
Q1 | – | Sell |
-25,679
| Closed | -$830K | – | 4800 |
|
|
2015
Q4 | $830K | Buy |
+25,679
| New | +$1.11M | 0.01% | 1941 |
|
Other funds holding GBT
Jane Street's GBT Position: Q4 2022 in Review
Jane Street sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 63,922 shares — an estimated $4.35M sold.
Jane Street first reported a position in GBT in Q4 2015 and held it in 22 quarters. The position peaked at $7.34M in Q2 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- Jane Street reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- Jane Street sold 63,922 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $4.35M.
- Jane Street first reported a position in Global Blood Therapeutics, Inc. in Q4 2015 and held it in 22 quarters.
- Jane Street's Global Blood Therapeutics, Inc. position peaked at $7.34M in Q2 2022.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.